Trial · NCT01589302
Adverse events158
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
141 to 158 of 158
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Memory Impairement | Nervous system disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Nervous System Disorders - Other | Nervous system disorders | Treatment (Ibrutinib) | 3 | 152 | 4 |
| serious | Syncope | Nervous system disorders | Treatment (Ibrutinib) | 2 | 152 | 2 |
| serious | Transient Ischemic Attacks | Nervous system disorders | Treatment (Ibrutinib) | 2 | 152 | 2 |
| serious | Tremor | Nervous system disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Psychiatric Disorders-Other | Psychiatric disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Renal and Urinary Disorders - Other | Renal and urinary disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Urinary Tract Obstruction | Renal and urinary disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Reproductive System and Breast Disorders - Other | Reproductive system and breast disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Dyspnea | Respiratory, thoracic and mediastinal disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Respiratory, Thoracic, and Mediastinal Disorders - Other | Respiratory, thoracic and mediastinal disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Rash Maculo-papular | Skin and subcutaneous tissue disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Surgical and Medical Procedures - Other | Surgical and medical procedures | Treatment (Ibrutinib) | 4 | 152 | 4 |
| serious | Hematoma | Vascular disorders | Treatment (Ibrutinib) | 1 | 152 | 2 |
| serious | Hypotension | Vascular disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Superior Vena Cava Syndrom | Vascular disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Thromboembolic Events | Vascular disorders | Treatment (Ibrutinib) | 2 | 152 | 2 |
| serious | Vascular Disorders- Other | Vascular disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01589302/events?page=8